Complement deposition, C4d, on platelets is associated with vascular events in systemic lupus erythematosus
Open Access
- 7 April 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (11), 3264-3274
- https://doi.org/10.1093/rheumatology/keaa092
Abstract
Complement components, including C4d, can be found on activated platelets, a process associated with vascular disease in SLE. We investigated whether platelet C4d (PC4d) adds additional value to traditional and known lupus-associated risk factors when identifying SLE patients with vascular disease. This cross-sectional study included 308 well-characterized SLE patients and 308 matched general population controls. PC4d deposition was analysed using flow cytometry. Values >95% of controls were considered as PC4d positive (+). aPL were determined by Luminex, and the LA test was performed by DRVVT. History of vascular disease (composite and as separate outcomes) was defined at inclusion. SLE patients had increased PC4d deposition as compared with population controls (50 vs 5%, P < 0.0001). PC4d+ positively associated with any vascular events, and separately with venous and cerebrovascular events, and also with all investigated aPL profiles. The association for any vascular event remained statistically significant after adjustment for traditional and SLE-associated risk factors (odds ratio: 2.3, 95% CI: 1.3, 4.3, P = 0.008). Compared with patients negative for both PC4d and LA, patients with double positivity were more likely to have vascular disease (odds ratio: 12.3, 95% CI: 5.4, 29.3; attributable proportion due to interaction 0.8, 95% CI: 0.4, 1.1) PC4d+ is associated with vascular events in SLE, independently of traditional and SLE-associated risk factors. Concurrent presence of PC4d and LA seem to interact to further increase the odds for vascular events. Prospective studies should examine whether the aPL/PC4d combination can improve prediction of vascular events in SLE and/or APS.Funding Information
- The King Gustaf V 80th Birthday Fund (SGI2014-0022, FAI-2017-0390)
- Swedish Research Council (2018-02535)
- Swedish Heart-Lung Foundation (20170257)
- Stockholm County Council (20170038)
- Swedish Rheumatism Association (R-739631)
- Swedish Society for Medicine and Ingegerd Johansson’s Foundation (SLS-713911)
This publication has 52 references indexed in Scilit:
- Oxidized low-density lipoproteins induce rapid platelet activation and shape change through tyrosine kinase and Rho kinase–signaling pathwaysBlood, 2013
- Cardiovascular event in systemic lupus erythematosus in northern Sweden: Incidence and predictors in a 7-year follow-up studyLupus, 2011
- Complement Component C3 Binds to Activated Normal Platelets without Preceding Proteolytic Activation and Promotes Binding to Complement Receptor 1The Journal of Immunology, 2010
- Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodiesLupus, 2009
- Complement classical pathway components are all important in clearance of apoptotic and secondary necrotic cellsClinical and Experimental Immunology, 2009
- Predictors of the first cardiovascular event in patients with systemic lupus erythematosus - a prospective cohort studyArthritis Research & Therapy, 2009
- Platelet C4d Is Associated With Acute Ischemic Stroke and Stroke SeverityStroke, 2008
- Complement activation triggered by chondroitin sulfate released by thrombin receptor‐activated plateletsJournal of Thrombosis and Haemostasis, 2008
- Systemic lupus erythematosus in a multiethnic US cohort (LUMINA): XXV. Smoking, older age, disease activity, lupus anticoagulant, and glucocorticoid dose as risk factors for the occurrence of venous thrombosis in lupus patientsArthritis & Rheumatism, 2005
- Homozygous C4A deficiency in systemic lupus erythematosus: analysis of patients from a defined populationClinical Genetics, 1990